Mindoula Expands Whole Person Care Enablement Platform Through Strategic Acquisitions
“The combination of Mindoula, Valera, and Janus gives both our existing partners and new partners the opportunity to…
Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions
AtaiBeckley’s lead program, BPL-003, is designed to provide durable relief from treatment-resistant depression Acquisition expands Lilly’s neuroscience pipeline…
Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada
Mississauga, ON, July 15, 2026 /PRNewswire/ – Septa Pharmaceuticals Inc., a rapidly growing leader in the Canadian healthcare…
Employee Well-Being Slips as Financial Stress Surges, Survey Finds
More than 1 in 4 employees report low well-being, according to a new report from WebMD Health Services. PORTLAND, Ore., June 18,…
Not Just a Headache: Year Three of Pfizer’s OOO for Migraine Awareness Campaign Aims to Make Migraine a Visible Priority at Work
Pfizer Canada, Migraine Canada, and Migraine Québec continue partnership to educate Canadians on the impact of migraine. Increasing…
Machine Learning Model Accurately Predicts Long-Term Risk of Type 2 Diabetes
Study of Over Three Million Patients for Risk of Type 2 Diabetes Demonstrates Potential for More Advanced Approach…
Novo Nordisk Introduces Extra Savings for Canadians Who Choose Ozempic®
MISSISSAUGA, ON, May 26, 2026 /CNW/ – Novo Nordisk Canada is announcing that effective Friday, May 29, 2026,…
Vi Launches Suite of AI Agents for Healthcare, Life Sciences, and Wellness Enterprises; Completes $145M Transaction at $1.64B Valuation
NEW YORK, May 19, 2026 /PRNewswire/ — Vi, the enterprise-AI platform for health, today announced a new suite…
Canada Facing $17.6 Billion Kidney Disease Crisis by 2050; Kidney Foundation Calls for Early Detection to Save Lives and Reduce Health Care Spending
New Deloitte report commissioned by The Kidney Foundation of Canada calls for early intervention to prevent up to…
Lifespan Vision Ventures Leads Violet Therapeutics’ $4.75M Seed Extension Financing
NORWALK, Conn., May 18, 2026 /CNW/ — Lifespan Vision Ventures (LVV), an investment firm focused on therapeutics that…
Lilly’s Foundayo and lower-dose Zepbound helped people maintain weight loss after switching from higher doses of injectable incretin therapy in two late-phase trials
In ATTAIN-MAINTAIN, participants who transitioned from a maximum tolerated dose (MTD) of Wegovy (semaglutide) to Foundayo maintained all…
Apotex launches Apo‑Semaglutide Injection™, a generic equivalent of Ozempic®, in Canada
TORONTO, May 14, 2026 /PRNewswire/ – Apotex Inc. (“Apotex” or the “Company”), the largest Canadian‑based global health company,…